Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East.

BACKGROUND: The varied clinical presentations of Helicobacter pylori (H. pylori) infection are most likely due to differences in the virulence of individual strains, which determines its ability to induce production of interleukin-8 (IL-8) in the gastric mucosa. The aim of this study was to examine association between cagA, vacA-s1 and vacA-s2 genotypes of H. pylori and severity of chronic gastritis and presence of peptic ulcer disease (PUD), and to correlate these with IL-8 levels in the gastric mucosa.
METHODS: Gastric mucosal biopsies were obtained from patients during esophagogastroduodenoscopy. The severity of chronic gastritis was documented using the updated Sydney system. H. pylori cagA and vacA genotypes were detected by PCR. The IL-8 levels in the gastric mucosa were measured by ELISA.
RESULTS: H. pylori cagA and/or vacA genotypes were detected in 99 patients (mean age 38.4±12.9; 72 males), of whom 52.5% were positive for cagA, 44.4% for vacA-s1 and 39.4% for vacA-s2; and 70.7% patients had PUD. The severity of inflammation in gastric mucosa was increased with vacA-s1 (p=0.017) and decreased with vacA-s2 (p=0.025), while cagA had no association. The degree of neutrophil activity was not associated with either cagA or vacA-s1, while vacA-s2 was significantly associated with decreased neutrophil activity (p=0.027). PUD was significantly increased in patients with cagA (p=0.002) and vacA-s1 (p=0.031), and decreased in those with vacA-s2 (p=0.011). The level of IL-8 was significantly increased in patients with cagA (p=0.011) and vacA-s1 (p=0.024), and lower with vacA-s2 (p=0.004). Higher levels of IL-8 were also found in patients with a more severe chronic inflammation (p=0.001), neutrophil activity (p=0.007) and those with PUD (p=0.001).
CONCLUSIONS: Presence of vacA-s1 genotype of H. pylori is associated with more severe chronic inflammation and higher levels of IL-8 in the gastric mucosa, as well as higher frequency of PUD. Patients with vacA-s2 have less severe gastritis, lower levels of IL-8, and lower rates of PUD. The presence of cagA genotype is not associated with the severity of gastritis or IL-8 induction in the gastric mucosa. The association of cagA with PUD may be a reflection of its presence with vacA-s1 genotype.

Background

Helicobacter pylori (H. pylori) colonizes the mucosa of the human stomach and establishes a long-term infection [1]. It leads to the development of chronic gastritis, peptic ulcer disease (PUD), mucosal-associated lymphoid tissue (MALT) lymphoma and gastric carcinoma [2,3]. The extent and severity of these associations depend on several elements, such as bacterial virulence factors, age of the host, genetic susceptibility, immune response and environmental factors [4-6].

The two key virulence markers of H. pylori are the cytotoxin associated A (cagA) and the vacuolating cytotoxin A (vacA) genes [6,7]. The cagA gene is not present in every H. pylori strain, but is associated with more severe clinical results such as more severe inflammation of the gastric mucosa, as well as higher prevalence of PUD and gastric carcinoma [8-10]. The vacA gene is present in all H. pylori strains and is associated with PUD [11]. The vacA gene contains at least three variable regions, the signal (s) region, intermediate (i) region and middle (m) region. The s-region exists as s1 and s2 types [12,13]. The vacA-s1 strains are associated with more severe gastric inflammation and PUD independently of cagA, while vacA-s2 strains are associated with lower ulcer prevalence and less severe inflammation [14].

H. pylori infection results in recruitment of neutrophils, lymphocytes and macrophages into the gastric mucosa through the induction of several cytokines such as TNF-α, IL-6 and IL-8 [15-17]. IL-8 is an important mediator in the immunopathogenesis of chronic gastritis caused by H. pylori [16]. It has been demonstrated that cagA and vacA-s1 positive strains of H. pylori induce production of IL-8 in the gastric mucosa, both in vivo and in vitro [16,18,19]. The vacA-s2 gene is not associated with IL-8 induction [18]. In addition, an association between the mucosal levels of IL-8 and severity of gastritis and presence of PUD has also been reported [19]. Most studies of association between genotypes of H. pylori and chronic gastritis, peptic ulcer disease and IL-8 levels have been conducted in the Western populations, and no previous study has examined these associations in the Middle East. Furthermore, the majority of published studies have only examined either a single or some of these associations.

The aim of this study was to determine the association between the presence of cagA, vacA-s1 and vacA-s2 genotypes in H. pylori and the severity of gastritis and PUD, and to correlate these with the levels of IL-8 in a group of patients from the Middle East. We have also attempted to examine all these inter-related associations in the same group of patients to validate the biologic plausibility that the bacterial virulence factors lead to induction of the cytokine IL-8, which in turn results in more severe inflammation or development of PUD.

Results

Esophagogastroduodenoscopy and gastric biopsies were performed in 120 adult patients. H. pylori were seen on histopathology in 98 of these patients, all of whom were positive for cagA and/or vacA. One patient had vacA on PCR but was not positive for H. pylori on histopathology was also included in the analysis. Therefore, further analysis was carried out in these 99 patients (72.7% males, 27.3% females; mean age 38.4 years) (Table 1). A history of PUD was present in 27.3% of the patients, and the most common indication for referral was dyspepsia (84.8%).

Table 1

Socio-demographic and clinical characteristics of 99 patients with infection in Kuwait

Characteristic
Age at diagnosis (years)
	Mean ± SD	38.4 ± 12.9
	Median	35.5
	Range	18-75
Gender		n	(%)
	Male	72	(72.7)
	Female	27	(27.3)
Nationality
	Kuwait	52	(52.5)
	Bangladesh	15	(15.2)
	Egypt	8	(8.1)
	State-less Arabs	5	(5.1)
	Syria	5	(5.1)
	Othera	14	(14.1)
Past history of peptic ulcer disease		27	(27.3)
Past history of H. pylori infection		4	(4.0)
History of cigarette smoking		38	(38.4)
History of alcohol consumption		6	(6.1)
Indication for esophagogastroduodenoscopy
	Dyspepsia	84	(84.8)
	Upper gastrointestinal bleeding	6	(6.1)
	Heartburn	5	(5.1)
	Anemia	2	(2.0)
	Persistent vomiting	2	(2.0)

aIndia (4), Iran (2), Pakistan (2), Saudi Arabia (2), Afghanistan (1), Jordan (1), Somalia (1), Yemen (1).

The most frequent abnormality seen on endoscopy was PUD (70.7%) (Table 2). Endoscopic evidence of mucosal inflammation of the stomach and duodenum was observed in 57.6% and 29.3% of the patients, respectively. Chronic inflammation was “None-Mild” in 22.2% of the patients, and “Moderate-Marked” in 77.8%. Neutrophil activity was “None-Mild” in 60.6%, and “Moderate-Marked” in 39.4% of the patients.

Table 2

Results of endoscopic, histological, genotype, and IL-8 level in patients with infection in Kuwait

Characteristic
			n	%
Esophagogastroduodenoscopy findingsa
	Duodenal ulcer		61	(61.6)
	Gastritis		57	(57.6)
	Duodenitis		29	(29.3)
	Gastric ulcer		13	(13.1)
	Esophagitis		10	(10.1)
	Gastric cancer		1	(1.0)
Histological findingsb
	H. pylori present		98	(99.0)
		None-Mild	44	(44.4)
		Moderate-Marked	54	(54.5)
	Chronic inflammation
		None-Mild	22	(22.2)
		Moderate-Marked	77	(77.8)
	Neutrophil activity
		None-Mild	60	(60.6)
		Moderate-Marked	39	(39.4)
	Glandular atrophy
		None-Mild	65	(65.7)
		Moderate-Marked	34	(34.3)
	Intestinal metaplasia
		None-Mild	94	(94.9)
		Moderate-Marked	5	(5.1)
H. pylori genotype
	cagA		52	(52.5)
	vacA-s1		44	(44.4)
	vacA-s2		39	(39.4)
	vacA-s1 + s2		10	(10.1)
	cagA + vacA-s1		31	(31.3)
	cagA + vacA-s2		8	(8.1)
	cagA + vacA-s1 + s2		7	(7.1)
IL-8 Level(pg/mg protein)
	Mean ± SD		1891.5 ± 1526.8
	Median (IQR)		1567.4 (1566.3)

aSome patients had more than one finding on endoscopy.

bAccording to the Updated Sydney system [40].

The presence of cagA, vacA-s1 and vacA-s2 genes was found in 52.5%, 44.4% and 39.4% of the patients, while 10.1% were positive for both vacA-s1 vacA-s2. The cagA gene was found in combination with vacA-s1 (cagA + vacA-s1) in 31.3% of the patients, with vacA-s2 (cagA + vacA-s2) in 8.1% and with both vacA-s1 and vacA-s2 (cagA + vacA-s1 + s2) in 7.1% of the patients. The IL-8 levels were available in 77 patients with a median value of 1567.4 (IQR 1566.3) pg/mg protein.

Table 3 shows the association between the H. pylori genotypes and severity of chronic inflammation, neutrophil activity and presence of PUD. Patients who were infected with H. pylori containing both the cagA and vacA-s1 genes were most likely to have “Moderate-Marked” degree of chronic inflammation (OR = 6.7, 95% CI: 1.4-31.4; p = 0.016). Patients with vacA-s1 gene alone also had a significantly more “Moderate-Marked” degree of chronic inflammation (OR = 3.9, 95% CI: 1.2-12.0; p = 0.017), while those with vacA-s2 had significantly less chronic inflammation (OR = 0.3, 95% CI: 0.1-0.8; p = 0.025). The presence of cagA or vacA-s1 genes either independently or together did not affect the severity of neutrophil activity in the gastric biopsies. Patients with vacA-s2 gene had a significantly less “Moderate-Marked” degree of neutrophil activity (OR = 0.3, 95% CI: 0.1-0.8; p = 0.027). The proportion of patients having PUD was highest in those with the cagA gene (OR = 4.8, 95% CI: 1.8-12.5; p = 0.002), followed by those with the vacA-s1 gene (OR = 2.8, 95% CI: 1.1-7.4; p = 0.031), while those with vacA-s2 had the lowest proportion of PUD (OR = 0.3, 95% CI: 0.1-0.7; p = 0.011). The presence of both cagA and vacA-s1 gene increased the risk of PUD more than the presence of these genotypes individually (OR = 6.3, 95% CI: 1.6-23.4; p = 0.006).

Table 3

Association between genotypes and chronic inflammation, neutrophil activity and peptic ulcer disease

H. pylori genotype a (n)		Chronic inflammation b				Neutrophil activity b				Peptic Ulcer Disease
		None-Mild	Moderate-Marked	OR (95% CI) c	p-value	None-Mild	Moderate-Marked	OR (95% CI) c	p-value	Absent	Present	OR (95% CI) c	p-value
		(n 22)	(n 77)			(n 60)	(n 39)			(n 29)	(n 70)
		n (%)	n (%)			n (%)	n (%)			n (%)	n (%)
cagA
	Positive (52)	8 (15.4)	44 (84.6)	2.4 (0.9-6.7)	0.074	29 (55.8)	23 (44.2)	1.5 (0.6-3.4)	0.325	8 (15.4)	44 (84.6)	4.8 (1.8-12.5)	0.002*
	Negative (47)	14 (29.8)	33 (70.2)	Reference		31 (66.0)	16 (34.0)	Reference		21 (44.7)	26 (55.3)	Reference
vacA-s1
	Positive (44)	5 (11.4)	39 (88.6)	3.9 (1.2-12.0)	0.017*	22 (50.0)	22 (50.0)	2.2 (0.9-5.2)	0.057	8 (18.2)	36 (81.8)	2.8 (1.1-7.4)	0.031*
	Negative (55)	17 (30.9)	38 (69.1)	Reference		38 (69.1)	17 (30.9)	Reference		21 (38.2)	34 (61.8)	Reference
vacA-s2
	Positive (39)	13 (33.3)	26 (66.7)	0.3 (0.1-0.8)	0.025*	29 (74.4)	10 (25.6)	0.3 (0.1-0.8)	0.027*	17 (43.6)	22 (56.4)	0.3 (0.1-0.7)	0.011*
	Negative (60)	9 (15.0)	51 (85.0)	Reference		31 (51.7)	29 (48.3)	Reference		12 (20.0)	48 (80.0)	Reference
vacA-s1 + S2
	Positive (10)	3 (30.0)	7 (70.0)	0.5 (0.1-2.2)	0.445	8 (80.0)	2 (20.0)	0.3 (0.0-1.7)	0.191	2 (20.0)	8 (80.0)	1.8 (0.3-9.1)	0.478
	Negative (89)	19 (21.3)	70 (78.7)	Reference		52 (58.4)	37 (41.6)	Reference		27 (30.3)	62 (69.7)	Reference
cagA + vacA-s1
	Positive (31)	2 (6.5)	29 (93.5)	6.7 (1.4-31.4)	0.016*	18 (58.1)	13 (41.9)	0.9 (0.9-1.0)	0.737	3 (9.7)	28 (90.3)	6.3 (1.6-23.4)	0.006*
	Negative (68)	20 (20.9)	48 (70.6)	Reference		42 (61.8)	26 (38.2)	Reference		26 (38.2)	42 (61.8)	Reference
cagA + vacA-s2
	Positive (8)	3 (37.5)	5 (62.5)	0.4 (0.1-2.2)	0.337	5 (62.5)	3 (37.5)	0.9 (0.2-4.3)	0.959	2 (25.0)	6 (75.0)	1.2 (0.2-6.5)	0.810
	Negative (91)	19 (20.9)	72 (79.1)	Reference		55 (60.4)	36 (39.6)	Reference		27 (29.7)	64 (70.3)	Reference
cagA + vacA-s1 + s2
	Positive (7)	2 (28.6)	5 (71.4)	0.9 (0.9-1.0)	0.255	5 (71.4)	2 (39.4)	0.5 (0.1-3.2)	0.537	1 (14.3)	6 (85.7)	2.7 (0.3-24.5)	0.359
	Negative (92)	20 (21.7)	72 (78.3)	Reference		55 (59.8)	37 (40.2)	Reference		28 (30.4)	64 (69.6)	Reference

aAll patients were positive for either cagA, vacA or both.

bAccording to the Updated Sydney system [40].

cAge and gender adjusted odds ratio.

*Statistically significant.

Table 4 shows the correlation between level of IL-8 in the gastric mucosa and H. pylori genotypes and histologic features and PUD. The median value for IL-8 was significantly higher in patients infected with H. pylori with cagA (p = 0.011) and vacA-s1 genes (p = 0.011 and 0.024, respectively); and significantly lower in those with vacA-s2 gene (p = 0.004) (Figure 1). The highest levels of IL-8 were found in patients who were positive for both cagA and vacA-s1 (Figure 2). Correlation of gastric mucosal IL-8 levels with the severity of chronic inflammation showed that patients who had “Moderate-Marked” chronic inflammation had significantly higher median IL-8 level compared to those who had “None-Mild” inflammation (p = 0.001) (Figure 3). Patients with “Moderate-Marked” neutrophil activity on gastric biopsy also had significantly higher median IL-8 levels compared to those who had “None-Mild” activity (p = 0.007). The median levels of IL-8 were also significantly elevated in the gastric biopsies of patients with PUD compared to those who did not have ulcers (p = 0.001). There was no significant difference in the density of H. pylori or degree of glandular atrophy or intestinal metaplasia with the IL-8 level in the gastric biopsies.

Table 4

Correlation between interleukin-8 and genotypes, chronic inflammation, neutrophil activity, and peptic ulcer disease

H. pylori genotype a			Interleukin-8 level b	p-value c
			Median (IQR)
	cagA
		Absent	1090.3 (1310.8)	0.011*
		Present	1885.7 (1281.6)
	vacA-s1
		Absent	1245.8 (1550.2)	0.024*
		Present	1840.0 (1098.6)
	vacA-s2
		Absent	1840.0 (1597.5)	0.004*
		Present	965.6 (1205.1)
	vacA-s1 + s2
		Absent	1541.1 (1566.3)	0.818
		Present	1711.8 (1928.7)
	cagA + vacA-s1
		Absent	1311.8 (1814.9)	0.021*
		Present	1901.7 (915.3)
	cagA + vacA-s2
		Absent	1577.5 (1548.6)	0.713
		Present	1331.7 (−)
	cagA + vacAs1 + s2
		Absent	1541.1 (1625.9)	0.807
		Present	1711.8 (1803.6)
Histological findingsd
	Chronic inflammation
		None-Mild	689.2 (1420.6)	0.001*
		Moderate-Marked	1835.7 (1345.3)
	Neutrophil activity
		None-Mild	1449.0 (1342.1)	0.007*
		Moderate-Marked	1917.8 (2703.6)
Peptic ulcer
	Absent		919.3 (1153.3)	0.001*
	Present		1890.6 (1638.4)

aAll patients were positive for either cagA, vacA or both.

bpg/mg protein.

cMann-Whitney U test.

dAccording to the Updated Sydney system [40].

*Statistically significant

Figure 1

Levels of interleukin-8 in the gastric mucosa in patients with with and without genotypes , -s1 and -s2. These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th percentile is indicated with a line, and the 10th and 90th percentiles are indicated with error bars. The p-values were calculated using the Mann–Whitney U test. *indicates that the p-value is statistically significant.

Figure 2

Levels of interleukin-8 in the gastric mucosa in patients with with and without genotypes   +  -s1,   +  -s2 and   +  -s1 +  -s2. These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th percentile is indicated with a line, and the 10th and 90th percentiles are indicated with error bars. The p-values were calculated using the Mann–Whitney U test. *indicates that the p-value is statistically significant.

Figure 3

Levels of interleukin-8 in the gastric mucosa in patients with and severity of chronic inflammation, neutrophil activity and peptic ulcer disease. These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th percentile is indicated with a line, and the 10th and 90th percentiles are indicated with error bars. The p-values were calculated using the Mann–Whitney U test. * indicates that the p-value is statistically significant.

A total of 58 (75.3%) patients who had “Moderate-Marked” chronic inflammation in the gastric mucosa had PUD, compared to 12 (54.5%) with “None-Mild”; while 31 (79.5%) patients with “Moderate-Marked” neutrophil activity had PUD, compared to 39 (65.0%) of those with “None-Mild” activity. However these differences were not statistically significant. There was also no association between the presence of PUD and severity of glandular atrophy, intestinal metaplasia or H. pylori density on gastric biopsies.

Discussion

To our knowledge, this is the first study to examine the association between the presence of cagA, vacA-s1 and vacA-s2 genotypes in H. pylori and the severity of chronic gastritis and PUD in a group of patients from the Middle East. We have also demonstrated the relationship of these factors with the levels of IL-8 in the gastric mucosa validating the biologic plausibility that these bacterial virulence factors lead to induction of the cytokine IL-8, which in turn results in more severe inflammation and/or development of PUD.

There appears to be a geographic variation in the association between H. pylori genotypes and gastric inflammatory response. Infection with cagA positive strains of H. pylori in Western countries is reported to cause more severe gastric inflammation compared to Asian countries, where the results have been inconsistent [7,20-24]. In our study both the degree of chronic inflammation and neutrophil activity in the gastric mucosa were more severe in patients who were infected with H. pylori containing the cagA and vacA-s1 genes. The presence of both cagA and vacA-s1 appeared to have a synergistic role in increasing the severity of inflammation in our patients. On the other hand, the presence of vacA-s2 appeared to improve the severity of chronic inflammation as well as neutrophil activity regardless of the presence of cagA, vacA-s1 or both. These findings are consistent with previously published studies where vacA-s2 strains were found to be associated with less inflammation [25]. Both the cagA and vacA-s1 genes were also independently associated with an increased risk of PUD, while the vacA-s2 gene appeared to have a lesser effect. Patients who had both the cagA and the vacA-s1 gene had the highest risk of PUD. On the other hand, the presence of vacA-s2 decreased the risk of PUD, whether it was present alone or with cagA, vacA-s1, or both. These results are similar to those reported from the Western countries [20,21,24], even though the majority of the patients in our study were from the Middle East and the Indian Subcontinent [26]. A recent study conducted to determine the genetic affinities of H. pylori isolates from ethnic Arabs in Kuwait found that these strains are closely related to the Indo-European group of the organism and clearly distinct from the East Asian strains [27]. This could be the reason why the association of cagA, vacA-s1 and vacA-s2 and gastritis and PUD in our patients seems to be similar to that reported from the Western countries.

The pro-inflammatory cytokine IL-8 plays an important role in the regulation of mucosal neutrophil migration and activation. Our results show that the level of IL-8 in the gastric mucosa was increased in presence of cagA and vacA-s1 genotypes of H. pylori and the highest levels were seen in patients who were positive for both these genes. The presence of vacA-s2 was associated with lower levels of IL-8. Significantly higher levels of IL-8 in the gastric mucosa were also seen in patients who had more severe degree of chronic inflammation and neutrophil activity in the gastric biopsies, as well as those who had PUD. These results are in agreement with previous reports where the levels of gastric mucosal IL-8 levels have been correlated with the presence of virulence H. pylori genes such as cagA and ice A [28,29]. However, some researchers have reported no difference in the IL-8 levels in patients with H. pylori infections with and without PUD [30], while others have higher levels in patients with PUD then those with only gastritis [31]. This inconsistency in the results of IL-8 production could be because of the differences in the methodologies used to measure the level of the cytokine in the gastric mucosa. We have used an ELISA based technique, which may be a more sensitive method of cytokine quantification.

With reference to other factors, we found no difference in the severity of gastritis, presence of PUD or levels of IL-8 between patients with or without history of smoking or alcohol consumption. The presence of PUD was however more frequent in this group of patients than has been reported previously from Kuwait as well as elsewhere [32]. The confounding effects of medications were minimized by only selecting those patients who had not been on any of the mentioned medications for at least 4 weeks prior to endoscopy. Several other H. pylori factors such as vacA-s1 subtypes (s1a and s1b), vacA middle region subtypes (m1 and m2), iceA and dupA genes can also affect the virulence of this organism and its effects on the gastric mucosa [33]. However, our study was not designed to determine these virulence factors, and this could be considered a limitation of this report. Besides bacterial factors, host genetics also contribute to the pathogenesis of gastroduodenal diseases [34,35]. In addition, many cytokine gene polymorphisms reveal different risk in gastric and duodenal ulcer patients [36,37].

Conclusions

This study which included patients from the Middle East shows that presence of H. pylori cagA and vacA-s1 genes results in induction of higher levels of the pro-inflammatory cytokine IL-8 in the gastric mucosa, which not only results in a more marked intensity of chronic inflammation and neutrophil activity in the gastric mucosa but also a higher occurrence of PUD. The presence of vacA-s2 results in lower levels of IL-8, as well as less severe inflammation and less PUD. In addition the presence of vacA-s2 appears to lessen the virulence effects of cagA and/or vacA-s1 genes.

Patients and methods

Patients and samples

The study population and the method of biopsy collection have been described previously [26,32]. Briefly, 120 consecutive, unselected adult patients referred for esophagogastroduodenoscopy were invited to participate in the study. Patients with coagulation abnormalities, prior gastro-duodenal surgery were excluded from the study. Patients who had taken histamine type 2 receptor antagonists, proton pump inhibitors, antibiotics, bismuth salts, aspirin or non-steroidal anti-inflammatory agents in the preceding four weeks were also excluded. The prevalence of cagA and vacA genotypes in these patients has been reported earlier [26].

Upper gastrointestinal endoscopy was performed in a standard manner. All endoscopes underwent a cleaning and disinfection process with an automated washer-disinfector before each procedure according to guidelines of the European Society of Gastrointestinal Endoscopy [38]. For each patient, four biopsies were taken from the gastric antrum, within 2 cm of the pylorus, using sterilized biopsy forceps.

Two biopsy specimens were fixed in buffered formalin, processed to paraffin, sectioned and stained with H&E and the HpSS [39]. All biopsies were examined individually by a senior gastrointestinal pathologist who was blinded to the clinical information about the patients. A biopsy was scored positive for H. pylori if organisms were seen on light microscopy. The updated Sydney system was used to score the density of H. pylori and degree of chronic inflammation, neutrophil activity, glandular atrophy and intestinal metaplasia on the biopsies [40]. Patients who had no or mild chronic inflammation in the gastric biopsy were combined in one group (None-Mild group), while those with moderate or marked degree of inflammation were included in the other group (Moderate-Marked group). Similarly, patients were divided into two groups (i.e. None-Mild and Moderate-Marked) for neutrophil activity, as well as for intestinal metaplasia and glandular atrophy.

The QIAamp® DNA mini kit (Qiagen, Hilden, Germany) was used to extract DNA from the biopsies. The purity of DNA was assessed calculating the ratio of optical density (OD) at 260–280 nm and the yield was quantified by absorbance at 260 nm.

PCR amplification of target DNA

Table 5 shows the primers used in this study. The cagAF and cagAR primers generate a fragment of 183 base pairs (bp) for the detection of cagA, while primers VA1F and VA1XRA yield a 176 bp fragment for vacA-s1 and 203 bp for vacA-s2 variants [41,42]. A pre-aliquoted PCR master mix (Abgene, Surrey, UK) was used for PCR amplification of target DNA. The final reaction volume was 50 μL and contained 25pmol of each primer and 50 ng DNA [43]. PCR was performed after preincubation at 94°C for 5 minutes, followed by 35 cycles at 94°C , 50°C and 74°C for one minute each followed by a 5 minutes final extension step at 74°C. The amplified samples were analyzed by electrophoresis on 2% high-resolution agarose gel in Tris–Acetate–EDTA (TAE) buffer, which was then stained with ethidium bromide at 0.5 μg/ml [44]. Ultraviolet light was used to visualize the bands of amplified DNA, which were then photographed.

Table 5

Primers used in PCR for amplification of , -s1 and -s2 sequences

DNA region amplified	Primer	Primer sequence	PCR product (bp a )
cagA	cagAF	5′-TTGACCAACAACCACAAACCGAAG-3′	183
	cagAR	5′-CTTCCCTTAATTGCGAGATTCC-3′
vacA-s1	VA1F	5′-ATGGAAATACAACAAACACAC-3′	176
	VA1XRA	5′-CCTGAAACCGTTCCTACAGC-3′
vacA-s2	VA1F	5′-ATGGAAATACAACAAACACAC-3′	203
	VA1XRA	5′-CCTGAAACCGTTCCTACAGC-3′

abp: Base pair.

Measurement of IL-8

Two biopsy specimens were frozen immediately in liquid nitrogen and stored at −80°C. These samples were later homogenized with 1 mL phosphate buffered saline (pH 7.4) for 1 minute at 4°C. The homogenate was then centrifuged for 10 minutes at 14,000 rpm. The supernatant obtained was used for estimation of IL-8 level as well as total protein measurement [45-47]. The IL-8 concentration was measured by IL-8 ELISA kit (Immunotech, Hamburg, Germany) in a sandwich type assay using the procedure recommended by the manufacturer. The modified Lowry method was used to measure the total protein in the homogenate [48]. The amount of IL-8 in the gastric mucosal biopsies was expressed as pg/mg protein.

Statistical analysis

The Student’s t-test was used to compare the difference between two means. We evaluated the association of PUD and severity of inflammation with the three H. pylori genotypes (cagA, vacA-s1 and vacA-s2) and their combinations. As our outcome measures were binary variables, we used univariate logistic regression models to test if any of the genotypes or their combinations are related to presence of the PUD or severity of inflammation. The strength of the association between these variables obtained from the regression models was expressed as the odds ratio (OR) and 95% Confidence Interval (95% CI) along with p-values. Further multivariate logistic regression models were used to obtain age and gender adjusted estimates of these effects. We used Mann–Whitney U tests to evaluate if the levels of IL-8 correlated with varying genotypes or their combinations, severity of inflammation and presence of PUD. We used non-parametric method as the cytokines were not normally distributed. A p-value of <0.05 was considered statistically significant. All p-values presented are two sided. The data were analyzed using the SPSS software (SPSS Inc., Chicago, IL, USA).

The protocol for the study, and the statement of informed consent, was approved by the ethical committee of the Medical Research Council of the Health Sciences Center at Kuwait University and conforms to the provisions of the World Medical Association’s Declaration of Helsinki in 1995 (as revised in Tokyo 2004). All patients gave an informed consent prior to inclusion in the study.